© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Mirum Pharmaceuticals, Inc. (MIRM) shows an Average True Range (ATR) of 3.1 and an Enterprise Value of 1.14B. Its average trading volume over the past 3 months is 645.34K, indicating liquidity. These fundamental metrics provide insight into MIRM's underlying financial health and market activity.
Mirum Pharmaceuticals, Inc. (MIRM) technical indicators as of January 1, 2026: the SMA 20 is 9.17%, SMA 50 at 10.7%, and SMA 200 at 32.91%. The RSI 14 value is 63.17, suggesting its current momentum. These technical analysis signals help assess MIRM's price trends and potential future movements.
Mirum Pharmaceuticals, Inc. (MIRM) stock performance overview as of January 1, 2026: The 52-week high is $82.58 (currently -4.35% below), and the 52-week low is $36.95 (currently 114.18% above). Over the past year, MIRM's performance is 87.31%, compared to the S&P 500's 12.29% change.
According to market data, Mirum Pharmaceuticals, Inc. (MIRM) stock's recent performance metrics show that over the last month, MIRM is 8.13%, with a Year-to-Date (YTD) performance of 91.03%. Over the past year, the stock has seen a 87.31% change. These figures summarize MIRM's price movements across various periods, reflecting its historical returns.
According to current financial data, MIRM stock's P/E (TTM) ratio is -112.00, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for MIRM, including P/S (8.35), P/B (15.89), and P/FCF (88.93), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.